}

 

tandem_web_icon_pump

 

 
 

The Tandem Diabetes Care Pump Access Program allows in-warranty, non-Tandem pump users to upgrade to the t:slim X2 insulin pump and choose from Control-IQ technology or Basal-IQ technology for the remainder of their current pump warranty.

 

If you qualify, and for a one-time payment (see table below), your new t:slim X2™ insulin pump will remain under warranty with us for the duration of your previous insulin pump’s warranty.

Why upgrade?

The t:slim X2 insulin pump now offers our Control-IQ™ advanced hybrid closed-loop technology, which can make diabetes management easier by predicting and helping to prevent highs and lows with automatic insulin adjustments, correction boluses,* and activity settings for sleep and exercise. Or, you can choose Basal-IQ™ technology, which predicts and helps prevent lows with no fingersticks required for calibration or mealtime dosing.† The t:slim X2 insulin pump is the only pump with Dexcom G6 continuous glucose monitoring (CGM) integration.‡

 

t:slim X2 Insulin Pump

 
 

 
 

Program Eligibility

To qualify for a t:slim X2 insulin pump with the Pump Access Program, you must:

  • Have at least six months of verifiable warranty remaining on your current insulin pump
  • Cover the cost of supplies through your provincial program, private insurance, or out-of-pocket
  • Not be eligible for a new pump through your provincial program or private plan

 

Your One-Time Payment

Time Remaining in Warranty Your Cost
2.5 years (or less) $1,399
2.5 to 4 years $1,899
More than 4 years $2,899

 

 
 

Upgrade your pump!

THIS OPPORTUNITY EXPIRES DECEMBER 31, 2022

Fill out your information and a Tandem Diabetes Care® representative will reach out to answer your questions and help you sign up for the t:slim X2 insulin pump with either Basal-IQ technology or Control-IQ technology (Terms and Conditions).

 

 

All fields are required. By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third-parties, except as noted in our privacy policy.

 
 

 

Notes Icon

Responsible Use of Predictive Technologies

Systems like the t:slim X2 insulin pump with Basal-IQ technology and the t:slim X2 insulin pump with Control-IQ technology are not substitutes for active diabetes management. For example, users still must bolus for meals. Basal-IQ technology is designed to predict and help prevent lows, but it cannot prevent all lows and Basal-IQ technology does not predict high glucose events. Control-IQ technology is designed to predict and help prevent low and high glucose events, but it cannot prevent all highs and lows, and Control-IQ requires that users accurately input information, such as meals and periods of sleep or exercise. The Basal-IQ and Control-IQ features rely on continuous CGM readings and will not be able to predict glucose levels and adjust insulin dosing if your CGM is not working properly or is unable to communicate with your pump. Be sure to always use your pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Always pay attention to your symptoms, actively monitor your glucose levels, and treat according to your healthcare provider’s recommendations.

 

* If glucose values are predicted to be above 10.0 mmol/l, Control-IQ technology calculates a correction bolus using the personal profile settings and a target of 6.1 mmol/l and delivers 60% of that value. An automatic correction bolus will not occur within 60 minutes of a bolus that has been delivered or cancelled.
† Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 continuous glucose monitoring (CGM) integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
‡ The Dexcom transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 insulin pump) and one consumer device (phone or tablet) at the same time.

Terms and Conditions

Tandem Diabetes Care Canada, Inc. (“Tandem”) offers eligible participants a t:slim X2 insulin pump with either Basal-IQ technology or Control-IQ technology (“Program Pump”) for an advance, one-time fee of $1,399 (2.5 years or less remaining in warranty), $1,899 (2.5 years to four years of remaining warranty), or $2,899 (more than four years of remaining warranty). Eligible participants will be entitled to use the Program Pump for the remainder of the warranty of participant’s current non-Tandem insulin pump (the “Program Period”).

Supplies can be purchased through Diabetes Express.

At the end of the Program Period, the Program Pump must be returned to Tandem within 30 days in the same condition in which it was received by participant (less reasonable wear and tear), or participant shall purchase the pump for $6,300, less the applicable program pump price.

During the time participant is authorized by Tandem to possess the Program Pump, it will be covered by Tandem’s standard warranty.

Confirmation of participant’s current warranty will be required to start the program. Tandem reserves the right to deny participation in the program in its sole discretion. This offer may be changed or discontinued at any time and will expire on December 31, 2022.

 

Important Safety Information

The pump and each System below is indicated for use in individuals six years of age and greater. The pump and each System is intended for single user use. The pump and each System is indicated for use with NovoRapid or Humalog U-100 insulin.

The t:slim X2 insulin pump with Basal-IQ technology (the Basal-IQ System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Basal-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings.

The t:slim X2 insulin pump with Control-IQ technology (the Control-IQ System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Control-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Control-IQ technology can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The t:slim X2 insulin pump with Control-IQ technology can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 insulin pump with Control-IQ technology is intended for the management of Type 1 diabetes.

Contraindications and Warning

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

 
Do not use the t:slim X2 insulin pump with Control-IQ technology if using hydroxyurea. Neither System is indicated for use in pregnant women, people on dialysis, or critically ill users. Users of the pump and either System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.